Journal article icon

Journal article

Novel treatments for hepatocellular cancer.

Abstract:

Hepatocellular cancer (HCC) has always been considered a therapeutic challenge, given the cytoxic drug resistant nature of the cancer and associated disorder in liver function, reducing the safety of many conventional chemotherapy agents. The Multikinase inhibitor sorafenib has been found to prolong survival in patients with advanced HCC, by around 3months compared to placebo, but novel treatments need to be explored. Current experimental therapeutic approaches encompass a broad range of scie...

Expand abstract
Publication status:
Published

Actions


Access Document


Authors


Journal:
Cancer letters
Volume:
286
Issue:
1
Pages:
114-120
Publication date:
2009-12-05
DOI:
EISSN:
1872-7980
ISSN:
0304-3835
URN:
uuid:8c1bdc42-a306-4149-8e56-65a57b9e56e3
Source identifiers:
246554
Local pid:
pubs:246554

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP